ANTIANGIOGENIC COMBINATION THERAPY FOR THE TREATMENT OF CANCER
摘要
<p>The present invention provides combinations of a DNA topoisomerase I inhibiting agent and a selective COX-2 inhibiting agent for preventing, treating, and/or reducing the risk of developing a neoplasia disorder in a mammal.</p>
